MedDataX Logo

Efficacy of Hip Strengthening on Dynamic Knee Stability, Disability and Gait in Knee Osteoarthritis

NCT ID: NCT04509830

Last Updated: 2020-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-01

Study Completion Date

2021-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study will be conducted to investigate the role of hip strengthening in improving dynamic knee stability, gait parameter, lower extremity strength and disability in knee osteoarthritis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

knee osteoarthritis accounts for more than 80% of the total burden of the diseases. patients with knee osteoarthritis had worse spatiotemporal gait parameter and dynamic instabitity. there are significant hip muscle weakness in knee osteoarthritis. hip muscle weakness leads to improper alignment and stress in knee joint. hip muscle strength can affect knee joint loading and disease progression in knee osteoarthritis. muscles of the lower extremity play a critical role in the preservation of normal knee joint function by providing dynamic knee joint stability and shock absorption, while maintaining safe transfer of forces across the joint.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized control trial
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors
double blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hip strengthening

resistance training for hip abductor, hip extensor, and hip external rotator will be performed.cuff weights will be used with 80% of 1 repetition maximum at 3 sets of 8 repetitions with 10-15 second rest between repetitions and 1-2 minute rest between sets.

Group Type EXPERIMENTAL

hip strengthening

Intervention Type OTHER

resistance training for hip abductor, hip extensor, and hip external rotator

quadriceps strengthening, stretch hamstring,cuff muscles

Intervention Type OTHER

multi-angle isometric quadriceps strengthening and hamstring and cuff self stretch

quadriceps strengthening, stretch for hamstring,cuff muscles

quadriceps strengthening: multi-angle isometric exercise from sitting position will be performed. cuff weights will be used with 3 sets of 12 repetitions at 40% of 1 reprtition maximum.

self stretch for hamstring and cuff muscles from supine position. the procedure will be repeated 4 times.

Group Type ACTIVE_COMPARATOR

quadriceps strengthening, stretch hamstring,cuff muscles

Intervention Type OTHER

multi-angle isometric quadriceps strengthening and hamstring and cuff self stretch

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hip strengthening

resistance training for hip abductor, hip extensor, and hip external rotator

Intervention Type OTHER

quadriceps strengthening, stretch hamstring,cuff muscles

multi-angle isometric quadriceps strengthening and hamstring and cuff self stretch

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

age 40 to 65 years grade 2-3 on KL grade BMI 25 to 32 kg/m2 medial KOA

Exclusion Criteria

* lateral KOA intraarticular corticosteriod injection into knee within pervious 3 months significant comorbidity individuals with known hip osteoarthritis previous trauma affection one or both hips history of other medical conditions affecting the knee joint previous replacement of any joint in the lower extremity low back pain cognitive impairment
Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

HebaAllah Elsayed Mohamed Elsaeed

head of physiotherapy department at Benha fever hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

heba elsaeed

Role: CONTACT

Phone: 01066451851

Email: [email protected]

Enas youssef

Role: CONTACT

Phone: 01127867507

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

hip strength on KOA

Identifier Type: -

Identifier Source: org_study_id